---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-207749"
form_type: "8-K"
ticker: null
cik: "0001538210"
company_name: "NexImmune, Inc."
filed_at: "2024-08-27T23:59:59+00:00"
generated_at: "2026-05-31T07:23:21.429410+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# NexImmune appoints wind-down officer; all directors and execs resign after shareholder-approved dissolution

## Summary
- All eight directors, including CEO Kristi Jones, CSO Mathias Oelke, and interim CFO Albert Marchio, resigned effective Aug 27, 2024.
- Craig Jalbert appointed as sole director, President, Treasurer, Corporate Secretary, and principal executive/financial officer effective Aug 27.
- Jalbert to receive $50,000/year for three years for winding down the company.
- Board approved filing certificate of dissolution with Delaware Secretary of State upon completion of wind-down.
- Company cautions trading in NEXI stock is highly speculative; urges extreme caution.

## SEC filing metadata
- accession: 0001193125-24-207749
- form_type: 8-K
- cik: 0001538210
- company_name: NexImmune, Inc.
- filed_at: 2024-08-27T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/d890897d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-207749
- JSON: https://secwatch.observer/filing/0001193125-24-207749.json
- Plain text: https://secwatch.observer/filing/0001193125-24-207749.txt

## Key facts
- Executive change
  Kristi Jones resigned as Director at NexImmune, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Craig Jalbert was appointed as President at NexImmune, Inc..
  - Action: appointed
  - Role: President
  source text: the Board also appointed Craig Jalbert, age 63, as the Company’s President, Treasurer and Corporate Secretary and as the Company’s principal executive officer, principal financial officer and principal accounting officer, effective as of August 27, 2024, and as the sole member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Kristi Jones resigned as Chief Executive Officer at NexImmune, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Leena Gandhi resigned as Director at NexImmune, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Sol J. Barer resigned as Director at NexImmune, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Alan S. Roemer resigned as Director at NexImmune, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Grant Verstandig resigned as Director at NexImmune, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Zhengbin (Bing) Yao resigned as Director at NexImmune, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Tim Bertram resigned as Director at NexImmune, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Albert N. Marchio II resigned as Interim Chief Financial Officer at NexImmune, Inc..
  - Action: resigned
  - Role: Interim Chief Financial Officer
  source text: The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Mathias Oelke resigned as Chief Scientific Officer at NexImmune, Inc..
  - Action: resigned
  - Role: Chief Scientific Officer
  source text: The resignations of Kristi Jones, the Company’s Chief Executive Officer, Mathias Oelke, the Company’s Chief Scientific Officer, and Albert N. Marchio II, the Company’s Interim Chief Financial Officer and its principal financial and accounting officer from the Company were not due to any disagreements with the Company on any matters relating to the Company’s operations, policies or practices.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm
- Executive change
  Paul D'Angio resigned as Director at NexImmune, Inc..
  - Action: resigned
  - Role: Director
  source text: On August 21, 2024, Sol J. Barer, Kristi Jones, Alan S. Roemer, Tim Bertram, Paul D’Angio, Grant Verstandig, Zhengbin (Bing) Yao and Leena Gandhi, each notified the Company of their respective resignations as members of the Company’s Board of Directors (the “Board”), effective as of August 27, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312524207749/0001193125-24-207749-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.